Privia Health Group

Privia Health Group, Inc. engages in the provision of healthcare services. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experience, and reward doctors for delivering care both in-person and via its Privia Platform, virtual care settings. The company was founded by Jeffrey Butler on November 7, 2007 and is headquartered in Arlington, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Privia Health Group reports robust Q1 performance and growth outlook

Privia Health Group delivered strong financial performance in Q1 2023, with growth in key metrics and a reaffirmation of guidance.
The company faces challenges in maintaining value-based care penetration and addressing analyst inquiries on market performance.
However, Privia Health's strategic focus on expansion, performance improvement, and shared savings generation presents promising opportunities.
Overall, Privia Health's resilience, growth trajectory, and strategic initiatives position them well for future success in the healthcare industry.

Privia Health Group reports robust Q2 growth and strategic expansion

Privia Health Group's Q2 performance reflects strong financial growth, operational stability, and strategic expansion into new markets and care models.
While facing challenges such as increased AR and market entry costs, the company's focus on value-based care and operational optimization positions it for long-term success.
With a robust leadership team, steady provider retention, and a clear growth strategy, Privia is well-positioned to capitalize on opportunities in value-based care and market expansion.

Privia Health Group excels in Q3, poised for growth

Privia Health Group's Q3 performance reflects robust growth in providers, patients, and financial metrics, underpinning its competitive strength and market positioning.
While facing challenges in maintaining growth rates and managing diverse healthcare segments, Privia's strategic focus on expansion and innovation presents growth opportunities.
With a solid financial foundation, innovative business model, and optimistic outlook, Privia is poised for continued success and value creation in the healthcare industry.

Privia Health Group excels in 2023, eyes growth amid challenges

Privia Health Group's strong financial performance, stable cash position, and strategic focus on growth and profitability position it well for future success.
While facing challenges in managing value-based risk arrangements and revenue declines from renegotiated contracts, Privia is adapting and pursuing growth opportunities.
With a solid patient base, prudent financial management, and a clear growth strategy, Privia is navigating market challenges and aiming for continued success in 2024.

Privia Health Group reports robust Q1 performance and eyes growth

Privia Health Group's Q1 2024 performance reflects strong growth and profitability, supported by a robust balance sheet and strategic focus on primary care-centric networks. While facing challenges from certain market exits, the company is well-positioned to capitalize on opportunities in risk arrangements and program enhancements for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Privia Health is a top IPO stock to watch during the stock market sell-off. Shares are holding up despite the stock market volatility.

IPO Stock Of The Week: 'Uber Of Managed Care' Privia Health Boasts RS Line At New High

ARLINGTON, Va., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to participate in a "fireside chat" Q&A session at the 2022 Global Healthcare Conference on Tuesday, September 13, 2022 beginning at 9:05 am ET.

Privia Health to Participate in the Baird 2022 Global Healthcare Conference

2021 Performance Across All Markets Demonstrates Improved Care and Lower Costs

UPDATE -- Privia Health Reports Results in CMS' Medicare Shared Savings Program

Privia Health Reports Results in CMS' Medicare Shared Savings Program

Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Robert Borchert - Senior Vice President, Investor and Corporate Communications Shawn Morris - Chief Executive Officer David Mountcastle - Executive Vice President and Chief Financial Officer Parth Mehrotra - President and Chief Operating Officer Conference Call Participants Joshua Raskin - Nephron Research LLC Albert Rice - Credit Suisse AG Lisa Gill - JPMorgan Chase & Co. Adam Ron - Bank of America Merrill Lynch Richard Close - Canaccord Genuity Group Inc. Whit Mayo - SVB Securities Gary Taylor - Cowen and Company, LLC David Larsen - BTIG LLC Taji Phillips - Jefferies Sandy Draper - Guggenheim Securities, LLC Jessica Tassan - Piper Sandler & Co. Operator Good day, and thank you for standing by. Welcome to the Privia Health Q2 2022 Conference Call.

Privia Health Group, Inc. (PRVA) CEO Shawn Morris on Q2 2022 Results - Earnings Call Transcript

Privia Health (PRVA) delivered earnings and revenue surprises of -400% and 7.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Privia Health (PRVA) Reports Q2 Loss, Tops Revenue Estimates

Privia Health easily beat second-quarter expectations for revenue and practice collections, leading the IPO stock to soar Thursday. The post Privia Health: The Self-Fashioned Uber Of Managed Care Is Extending Its Run appeared first on Investor's Business Daily.

Privia Health: The Self-Fashioned Uber Of Managed Care Is Extending Its Run

ARLINGTON, Va., July 13, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its second quarter and six month periods ended June 30, 2022 before market open on Thursday, August 11, 2022.

Privia Health to Report Second Quarter 2022 Results on Thursday, August 11

Privia Health (PRVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Privia Health (PRVA) Moves 7.4% Higher: Will This Strength Last?

ARLINGTON, Va., June 27, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named a recipient of the 2022 MAP Award for High Performance in Revenue Cycle, sponsored by the Healthcare Financial Management Association (HFMA).

Privia Receives HFMA's MAP Award for High Performance in Revenue Cycle for Seventh Straight Year

Privia Health (PRVA) Surges 8.1%: Is This an Indication of Further Gains?

Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Robert Borchert – Senior Vice President-Investor and Corporate Communications Shawn Morris – Chief Executive Officer Parth Mehrotra – President and Chief Operating Officer David Mountcastle – Chief Financial Officer Conference Call Participants Josh Raskin – Nephron Research A.J. Rice – Credit Suisse Lisa Gill – J.P.

Privia Health Group's (PRVA) CEO Shawn Morris on Q1 2022 Results - Earnings Call Transcript

Privia Health (PRVA) delivered earnings and revenue surprises of 500% and 5.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Privia Health (PRVA) Tops Q1 Earnings and Revenue Estimates

ARLINGTON, Va., May 12, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2022.

Privia Health Reports First Quarter 2022 Financial Results

Privia Health (PRVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Privia Health (PRVA) Q1 Earnings Expected to Decline

ARLINGTON, Va., April 11, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2022 before market open on Thursday, May 12, 2022.

Privia Health to Report First Quarter 2022 Results on Thursday, May 12

ARLINGTON, Va., March 31, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced the addition of Nancy Cocozza to its Board of Directors, increasing its Board to ten members. Ms. Cocozza, a former senior vice president and Medicare business leader with Aetna, will also serve on the Board's Audit Committee.

Nancy Cocozza Joins Privia Health's Board of Directors

Privia Health Group, Inc. (PRVA) CEO Shawn Morris on Q4 2021 Results - Earnings Call Transcript

ARLINGTON, Va., March 22, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2021.

Privia Health Reports Fourth Quarter 2021 Financial Results

WILMINGTON, Del.--(BUSINESS WIRE)-- #clinical--Amalgam Rx, Inc., a leader in connecting healthcare providers, payers, and life sciences companies through a SaaS-enabled digital marketplace and product platform, and Privia Health Group, Inc., a national physician enablement company, announced a collaboration for multiple EHR-integrated services. Leveraging Amalgam's real-time, point-of-care decision support engine, the companies are working together to simplify and enhance the way providers practice value-b

Privia Health Leverages Amalgam Rx's EHR-Integrated Solutions to Personalize Care

ARLINGTON, Va., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that the Company's management team will participate in a virtual fireside chat as part of the SVB Leerink 11th Annual Global Healthcare Conference on Wednesday, February 16, 2022, beginning at 4:20 pm ET.

Privia Health to Participate in SVB Leerink Virtual Healthcare Conference

WINSTON-SALEM, N.C., Feb. 14, 2022 /PRNewswire/ --  Javara, a leading Integrated Research Organization focused on delivering access to clinical trials at the point of care, today announced an opportunity for adults age 60 or older who live in the Fayetteville, Georgia; Annapolis, Maryland; or Fort Worth, Texas areas to participate in a clinical trial of a new investigational vaccine aimed at protecting them from the respiratory syncytial virus (RSV).

Javara Contributes to RSV Prevention Vaccine Trial in Collaboration with Privia Health and Moderna

ARLINGTON, Va. and BRENTWOOD, Tenn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) and Surgery Partners, Inc. (Nasdaq: SGRY) today announced a strategic agreement whereby Surgery Partners will leverage the physician enablement capabilities of Privia Health in the state of Montana, and Privia Health will build out a statewide physician provider network that will benefit from Surgery Partners high-value surgical capabilities.

Privia Health Partners with Surgery Partners; Enters Montana Market

ARLINGTON, Va., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for the fourth quarter and full year ended December 31, 2021 before market open on Friday, March 25, 2022.

Privia Health to Report Fourth Quarter 2021 Results on Friday, March 25

ARLINGTON, Va., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), today announced it has launched three new Accountable Care Organizations (“ACOs”) in Maryland, Florida and Tennessee, each of which are participating in the Medicare Shared Savings Program (“MSSP”). This expands the total number of Privia-owned ACOs to seven, including its existing ACOs in Georgia, Gulf Coast Texas, North Texas and Virginia.

News for Privia Health Group Stock (PRVA)